Beta-thromboglobulin and platelets in unstable angina;Niestabilna choroba wieńcowa β-tromboglobulina i płytki krwi

Kardiologia Polska

Volumn 58, Issue 6, 2003, Pages 449-456

  Butkiewicz, Anna Maria ^a   Kemona, Halina ^a   Dymicka Piekarska, Violetta ^a   Bychowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Platelet activation; Unstable angina; Thromboglobulin

Indexed keywords

BETA THROMBOGLOBULIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; UNSTABLE ANGINA PECTORIS;

EID: 0038269849     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schneider D.J., Tracy P.B., Sobel B.E.: Ostre zespoły wieńcowe. Rola płytek. Medycyna po dyplomie, 1999, 8, 155-61.
2. Ulutin T., Sonmez H., Ucisik N. et al.: The molecular markers of hemostatic activation on coronary artery disease. Thromb. Res. 1997, 88, 329-32.
3. Kopeć M.: Patofizjologia i klinika zakrzepu. Hematologia kliniczna, t. II, Janicki K. PZWL, Warszawa 1992, 615-50.
4. Czokało-Plichta M.: Patofizjologia hemostazy płytkowej. Patofizjologia. PZWL Warszawa wydanie II, 1998, rozdział 10, 535-45.
5. Salvioni A., Perego G. B., Marenzi G. et al.: Platelet activity in early stage of acute myocardial infarction: Relation to time of presentation, treatment with either tissue plasminogen activator or streptokinase and cyclooxygenase inhibition. J. Thromb. Thrombolysis, 1998, 5, 65-71.
6. Mundal H.H., Hjemdahl P., Urdal P. et al.: Beta-thromboglobulin in urine and plasma: influence of coronary risk factors. Thromb. Res. 1998, 90, 229-37.
7. Bath P.M.W., Butterworth R.J.: Platelet size: measurement, physiology and vascular disease. Blood Coagulation and Fibrinolysis, 1996, 7, 157-61.
8. Brown A.S., Martin J.F.: The megacaryocyte platelet system and vascular disease. Eur. J. Clin. Invest., 1994, 24, Suppl. 1, 9-15.
9. Endler G., Klimesch A., Sunder-Plassmann H. et al.: Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br. J. Haematol. 2002, 117, 399-404.
10. Park Y., Schoene N., Harris W.: Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets, 2002, 13, 301-6.
11. Pizzulli L., Yang A., Martin J.F. et al.: Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur. Heart J. 1998, 19, 80-4.
12. Senaran H., Ileri M., Altinbas A. et al.: Thrombopoietin and mean platelet volume in coronary artery disease. Clin. Cardiol. 2001, 24, 405-8.
13. Stogowski A., Kemona H., Prokopowicz J.: Ocena parametrów morfologicznych płytek krwi w zawale mi̧śnia sercowego. Diagn. Lab. 1996, 32, 771-8.
14. Moshfegh K., Redondo M., Julmy F. et al.: Antiplatelet effects of Clopidogrel compared with aspirin after myocardial infarction. Enhanced inhibitory effects of combination therapy. J. Am. Coll. Cardiol. 2000, 36, 699-705.
15. Nakajima T., Kawazoe K., Ishibashi K. et al.: Reduction of heparin dose is not beneficial to platelet function. Ann. Thorac. Surg. 2000, 70, 186-190.
16. Dymicka-Piekarska V., Kemona H., Mantur M. et al.: β-thromboglobulin in patients with acute myocardial infarction according to the treatment. Rocz. Akad. Med. Białystok, 2001, 46, 145-52.
17. Hurlen M., Seljeflot I., Arnesen H.: Increased platelet aggregabillity during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb. Res. 2000, 99, 487-94.
18. Sadayasu T., Nakashima Y., Yashiro A. et al.: Heparin-releasable platelet factor 4 in patients with coronary artery disease. Clin. Cardiol. 1991, 14, 725-9.
19. Korovesis S., Fredericks S. et al.: Release of platelet activation markers during coronary angioplasty. Coron. Artery. Dis. 2000, 11, 391-8.
20. Martin J.F., Plumb J., Kilbely R.S.: Changes in volume and density of platelet in myocardial infarction. Br. Med. J. 1983, 287, 456-9.
21. Sewell R., Ibbotson R.M., Philips R. et al.: High mean platelet volume after myocardial infarction: is it due consumption of small platelets? Br. Med. J. 1984, 289, 1576-80.
22. Erne P., Wardle J., Sanders K. et al.: Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb. Haemost. 1988, 59, 259-61.